These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27011370)

  • 1. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome.
    Wang B; Hao M; Yang Q; Li J; Guo Y
    J Assist Reprod Genet; 2016 Jul; 33(7):959-65. PubMed ID: 27011370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of sRAGE in follicular fluid from patients with PCOS.
    Wang B; Li J; Yang Q; Zhang F; Hao M; Guo Y
    Reproduction; 2017 Mar; 153(3):285-292. PubMed ID: 27965400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
    Emami N; Alizadeh A; Maleki-Hajiagha A; Dizavi A; Vesali S; Moini A
    J Ovarian Res; 2023 Jun; 16(1):127. PubMed ID: 37391740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation.
    Wang BJ; Qian L; Li J; Wang F; Yang QL; Li G; Liang YL; Guo YH
    Gynecol Endocrinol; 2020 Feb; 36(2):148-151. PubMed ID: 31248316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.
    Garg D; Grazi R; Lambert-Messerlian GM; Merhi Z
    J Assist Reprod Genet; 2017 Nov; 34(11):1507-1513. PubMed ID: 28825156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between follicular fluid sRAGE level and ovarian responsiveness in non-PCOS patients undergoing controlled ovarian hyperstimulation].
    Li M; Shao Y; Fu H; Zhou C; Yao B; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1482-1486. PubMed ID: 31907148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inflammatory State of Follicular Fluid Combined with Negative Emotion Indicators can Predict Pregnancy Outcomes in Patients with PCOS.
    Huang X; Yin Z; Xu J; Wu H; Wang Y
    Reprod Sci; 2024 Aug; 31(8):2493-2507. PubMed ID: 38653858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome.
    Li Z; Zhu Y; Li H; Jiang W; Liu H; Yan J; Chen ZJ; Li W
    Reprod Biomed Online; 2018 Apr; 36(4):483-489. PubMed ID: 29397316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and female infertility: the role of follicular fluid soluble receptor of advanced glycation end-products (sRAGE) in women with endometriosis.
    Sopasi F; Spyropoulou I; Kourti M; Vasileiadis S; Tripsianis G; Galazios G; Koutlaki N
    Hum Fertil (Camb); 2023 Dec; 26(6):1400-1407. PubMed ID: 37811816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.
    Niu Z; Ye Y; Xia L; Feng Y; Zhang A
    Cytokine; 2017 Mar; 91():180-186. PubMed ID: 28082237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles.
    Amato G; Conte M; Mazziotti G; Lalli E; Vitolo G; Tucker AT; Bellastella A; Carella C; Izzo A
    Obstet Gynecol; 2003 Jun; 101(6):1177-82. PubMed ID: 12798522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
    Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
    Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS).
    Artimani T; Karimi J; Mehdizadeh M; Yavangi M; Khanlarzadeh E; Ghorbani M; Asadi S; Kheiripour N
    Gynecol Endocrinol; 2018 Feb; 34(2):148-152. PubMed ID: 28868943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
    Merhi Z; Irani M; Doswell AD; Ambroggio J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome.
    Zhou D; Li S; Li W; Yin T; Xu W; Zhang J; Yang J
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():106-112. PubMed ID: 28964971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
    Nejabati HR; Mota A; Farzadi L; Ghojazadeh M; Fattahi A; Hamdi K; Nouri M
    J Endocrinol Invest; 2017 Feb; 40(2):207-215. PubMed ID: 27664102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
    Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.